Introduction
Sezary Syndrome, various cancer, Cancer
MYCOSIS FUNGOIDES, SEZARY SYNDROME, CYTOTOXICITY, ADULT T-CELL LEUKEMIA-LYMPHOMA, CANCER
Cancer immunotherapy is now more frequently used in clinical practice and immune checkpoint inhibitors (ICIs) have improved the prognosis of patients with various cancer types; however, their efficacy is still insufficient [KW-0761 (mogamulizumab) is a humanized anti-C-C chemokine receptor type 4 (CCR4) IgG1 monoclonal antibody (mAb) with enhanced antibody-dependent cellular cytotoxicity. Since CCR4 is overexpressed in relapsed Adult T-cell leukemia-lymphoma, Mycosis Fungoides, and Sezary Syndrome [